Skip to main content

DISEÑO DE DISPOSITIVOS MEDICOS Y DESARROLLO DE RECUBRIMIENTOS BIOCIDAS ACTIVOS MEDIANTE SISTEMAS MICROFLUIDICOS

PID2021-127847OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Enhanced efficiency of Pd(0)-based single chain polymeric nanoparticles for in vitro prodrug activation by modulating the polymer’s microstructure

  • Deng, Linlin
  • Sathyan, Anjana
  • Adam, Catherine
  • Unciti-Broceta, Asier
  • Sebastián, Víctor
  • Palmans, Anja R. A.
Bioorthogonal catalysis employing transition metal catalysts is a promising strategy for the in situ synthesis of imaging and therapeutic agents in biological environments. The transition metal Pd has been widely used as a bioorthogonal catalyst, but bare Pd poses challenges in water solubility and catalyst stability in cellular environments. In this work, Pd(0) loaded amphiphilic polymeric nanoparticles are applied to shield Pd in the presence of living cells for the in situ generation of a fluorescent dye and anticancer drugs. Pd(0) loaded polymeric nanoparticles prepared by the reduction of the corresponding Pd(II)-polymeric nanoparticles are highly active in the deprotection of pro-rhodamine dye and anticancer prodrugs, giving significant fluorescence enhancement and toxigenic effects, respectively, in HepG2 cells. In addition, we show that the microstructure of the polymeric nanoparticles for scaffolding Pd plays a critical role in tuning the catalytic efficiency, with the use of the ligand triphenylphosphine as a key factor for improving the catalyst stability in biological environments., A.S., L.D., A.R.A.P., and A.U.-B. gratefully acknowledge funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant Agreement no. 765497 (THERACAT). C.A. and A.U.-B. thank EPSRC (EP/N021134/1 and EP/S010289/1) for funding. V.S. acknowledges funding from projects PID2021-127847OB-I00 MCIN/AEI/10.130 and PDC2022-133866-I00 MCIN/AEI/10.13039/501100011033 and Fundación Ramón Areces (XX concurso nacional-ciencias de la vida y la materia). We also thank CIBER-BBN, an initiative funded by the VI National R&D&i Plan 2008–2011 financed by the Instituto de Salud Carlos III and by Fondo Europeo de Desarrollo Regional (Feder) “Una manera de hacer Europa”, with the assistance of the European Regional Development Fund. LMA-ELECMI and NANBIOSIS ICTs are gratefully acknowledged., Peer reviewed